📊 Midday Market Take

Happy hump day, friends. The most recent session closed nearly flat across the board, with the S&P 500 and Nasdaq each slipping a tiny 0.08% and the Dow managing a quiet 0.32% gain.

Keep an eye on industrials when markets reopen Thursday, since the Dow's outperformance hints that old-economy names are quietly holding the fort. If you have exposure there, no reason to flinch, but trimming into any strength before the long Juneteenth weekend is a reasonable move.

uniQure N.V.

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding.

3 Reasons to Watch QURE

• FDA Clears Path for Huntington's Therapy Filing. uniQure just got the green light from the FDA to submit its Huntington's disease gene therapy for approval, a massive regulatory hurdle that sent shares surging over 60% in a single session. When markets reopen, investors will be watching to see if that momentum holds or if traders start locking in gains after one of biotech's biggest single-day moves in recent memory.
• The Stock Has More Than Doubled in 30 Days. A 74% jump on Wednesday landed on top of an already staggering 106% gain over the past month, meaning this isn't a one-day story that came out of nowhere. The multi-week run signals growing conviction around uniQure's gene therapy pipeline, and the question now is whether fresh buyers step in or the stock takes a breather after such a violent move higher.
• One-Year Return of 218% Rewrites the Story. A year ago, uniQure was a very different stock, but an 218% gain over the past 12 months tells you the market has been steadily repricing what this company could be worth. With a potential Huntington's approval now on the table alongside its existing hemophilia B therapy HEMGENIX, investors will be sizing up whether the valuation still has room to run.

Top Market Headlines

Is Casey's General Stores (CASY) Outperforming Other Retail-Wholesale Stocks This Year?

Here is how Casey's General Stores (CASY) and Murphy USA (MUSA) have performed compared to their sector so far this year.

2 Under-$15 AI Stocks as the AI Boom Hits New Highs (Ad)

Dell just shocked Wall Street with booming AI server sales, and AI names are leading the market to records. But the giants aren't the only play — here are two under-the-radar AI stocks still trading under $15.

3 Dividend Growth Stocks to Buy as Global Oil Prices Tumble

Global oil prices hit a 3-month low, and stocks like DELL stand out for revenue growth, earnings outlooks, and dividend payouts.

Best Growth Stocks to Buy for June 17th

DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 17, 2026.

America's New AI "Mega Computer" to Span an Area Bigger than the State of Texas (Ad)

The AI boom has been stalled for months. But according to legendary tech investor Louis Navellier, that's about to change. The world's first AI "Mega Computer" — Golden Dawn — will come online in 2026. It will cover a territory larger than the state of Texas… and be more than 1 trillion times more powerful than Elon Musk's Colossus. This company's building it right now.

The Best Soaring "Strong Buy" Stocks to Buy Now as the Market Rebounds

How investors can find the best "Strong Buy" momentum stocks to add to their portfolios right now in June and heading into the second half of 2026.

Do this before Elon's next tweet (Ad)

I believe Elon is about to make his latest invention available to the public. When he does, sales could go through the roof. And the stock price of one of his critical partners could soar. I expect Elon to make this announcement any day now. By the end of the month at the latest. But you never know with Elon… He could post it on X tomorrow. So, there's very little time to act.